Barclays reissued their overweight rating on shares of SEGRO (LON:SGRO – Free Report) in a research note released on Monday morning, Marketbeat.com reports. They currently have a GBX 1,050 ($13.73) target price on the real estate investment trust’s stock.
Other equities analysts have also issued reports about the company. JPMorgan Chase & Co. boosted their price target on SEGRO from GBX 1,000 ($13.08) to GBX 1,050 ($13.73) and gave the company an overweight rating in a research note on Thursday, August 22nd. UBS Group lowered SEGRO to a neutral rating and lowered their price target for the company from GBX 1,045 ($13.67) to GBX 985 ($12.88) in a research note on Tuesday, August 20th. Jefferies Financial Group decreased their price objective on SEGRO from GBX 950 ($12.42) to GBX 930 ($12.16) and set a hold rating on the stock in a report on Monday, July 29th. Finally, Shore Capital reaffirmed a buy rating on shares of SEGRO in a report on Wednesday, September 4th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of Moderate Buy and an average price target of GBX 986.50 ($12.90).
View Our Latest Stock Report on SEGRO
SEGRO Trading Down 0.7 %
SEGRO Cuts Dividend
The business also recently disclosed a dividend, which will be paid on Friday, September 20th. Shareholders of record on Thursday, August 8th will be issued a dividend of GBX 9.10 ($0.12) per share. This represents a yield of 1%. The ex-dividend date of this dividend is Thursday, August 8th. SEGRO’s payout ratio is -13,333.33%.
SEGRO Company Profile
SEGRO is a UK Real Estate Investment Trust (REIT), listed on the London Stock Exchange and Euronext Paris, and is a leading owner, manager and developer of modern warehouses and industrial property. It owns or manages 10.4 million square metres of space (112 million square feet) valued at £20.7 billion serving customers from a wide range of industry sectors.
See Also
- Five stocks we like better than SEGRO
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
- Stock Market Upgrades: What Are They?
- GameStop: Earnings Won’t Save It, Dilution Points to Trouble
- Where Do I Find 52-Week Highs and Lows?
- Dividend Aristocrats or Dividend Kings: Which Is Best for You?
Receive News & Ratings for SEGRO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SEGRO and related companies with MarketBeat.com's FREE daily email newsletter.